Results for tag: "Community Acquired Bacterial Pneumonia Drug"

Community Acquired Bacterial Pneumonia (CABP) is a type of pneumonia caused by bacteria that is acquired outside of a hospital setting. It is one of the most common types of pneumonia and is treated with antibiotics. Respiratory drugs are used to treat CABP and other respiratory illnesses, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These drugs are used to reduce inflammation, open airways, and reduce mucus production. They can also be used to prevent and treat infections. The CABP drug market is a subset of the larger respiratory drug market. It includes antibiotics, anti-inflammatory drugs, and other medications used to treat CABP. These drugs are available in both generic and branded forms. The market is highly competitive, with many companies offering similar products. Some companies in the CABP drug market include Pfizer, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more